Target intelligence / Profile preview

Cell division cycle 25A mRNA 3' untranslated region (CDC25A mRNA 3' UTR)

Target
CDC25A mRNA 3' UTR
Molecular classification
RNA, Untranslated region, Regulatory element
01

Overview

The Cell division cycle 25A (CDC25A) mRNA 3' untranslated region (UTR) is a key regulatory sequence located at the 3' end of the CDC25A messenger RNA. CDC25A itself is a dual-specificity phosphatase that plays a pivotal role in the cell cycle by activating cyclin-dependent kinases (CDKs), specifically triggering the G1/S and G2/M transitions (UniProt: P30304). The 3' UTR serves as a hub for post-transcriptional control, containing binding sites for various microRNAs (miRNAs) such as miR-21, miR-34a, and miR-449a, which regulate mRNA stability and translation (PubMed: 17574024, 19448674). In many human cancers, CDC25A is frequently overexpressed, often correlating with poor prognosis and aggressive tumor behavior, making its regulatory elements attractive therapeutic targets (PubMed: 15933744). Therapeutic strategies targeting the CDC25A mRNA 3' UTR include the use of miRNA mimics or antisense oligonucleotides (ASOs) to induce mRNA degradation or block translation, thereby inhibiting cell proliferation. While promising, these approaches face challenges regarding delivery efficiency and the potential for off-target effects on other transcripts sharing similar regulatory motifs.

Other names
CDC25A 3'-UTRCell division cycle 25 homolog A mRNA 3' untranslated regionCDC25A 3' untranslated region
02

Mechanism of action

RNA interference (RNAi) or antisense-mediated degradation and translational repression of the CDC25A transcript by binding to specific regulatory motifs within the 3' UTR.

03

Biological functions

Post-transcriptional regulationmRNA stabilityTranslation regulationCell cycle control
04

Disease associations

CancerBreast cancerLung cancerHepatocellular carcinomaColorectal cancer
05

Safety considerations

Off-target effects on other mRNA transcriptsSystemic delivery challengesPotential for widespread cell cycle disruption in healthy tissuesInnate immune activation by synthetic RNA molecules
06

Interacting drugs

miR-21 mimics

4 more in the full profile.

07

Biomarkers

CDC25A mRNA expression levelsmiR-21 expression levelsmiR-34a expression levelsCell proliferation index (Ki-67)

Beyond the preview

Go deeper on Cell division cycle 25A mRNA 3' untranslated region (CDC25A mRNA 3' UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell division cycle 25A mRNA 3' untranslated region (CDC25A mRNA 3' UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call